GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lantheus Holdings Inc (FRA:0L8) » Definitions » Cyclically Adjusted PB Ratio

Lantheus Holdings (FRA:0L8) Cyclically Adjusted PB Ratio : 50.18 (As of May. 17, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Lantheus Holdings Cyclically Adjusted PB Ratio?

As of today (2024-05-17), Lantheus Holdings's current share price is €73.26. Lantheus Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €1.46. Lantheus Holdings's Cyclically Adjusted PB Ratio for today is 50.18.

The historical rank and industry rank for Lantheus Holdings's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:0L8' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 37.07   Med: 214.4   Max: 1759
Current: 48.43

During the past years, Lantheus Holdings's highest Cyclically Adjusted PB Ratio was 1759.00. The lowest was 37.07. And the median was 214.40.

FRA:0L8's Cyclically Adjusted PB Ratio is ranked worse than
99.25% of 671 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs FRA:0L8: 48.43

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lantheus Holdings's adjusted book value per share data for the three months ended in Mar. 2024 was €12.553. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.46 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Lantheus Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Lantheus Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lantheus Holdings Cyclically Adjusted PB Ratio Chart

Lantheus Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 60.70

Lantheus Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,702.09 228.84 60.70 37.87

Competitive Comparison of Lantheus Holdings's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Lantheus Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lantheus Holdings's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lantheus Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lantheus Holdings's Cyclically Adjusted PB Ratio falls into.



Lantheus Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Lantheus Holdings's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=73.26/1.46
=50.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lantheus Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Lantheus Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=12.553/131.7762*131.7762
=12.553

Current CPI (Mar. 2024) = 131.7762.

Lantheus Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201406 -6.395 100.560 -8.380
201409 -6.779 100.428 -8.895
201412 -7.098 99.070 -9.441
201503 -8.357 99.621 -11.054
201506 -5.744 100.684 -7.518
201509 -5.580 100.392 -7.324
201512 -5.602 99.792 -7.397
201603 -5.150 100.470 -6.755
201606 -4.873 101.688 -6.315
201609 -3.023 101.861 -3.911
201612 -2.747 101.863 -3.554
201703 -2.551 102.862 -3.268
201706 -2.077 103.349 -2.648
201709 -1.743 104.136 -2.206
201712 0.521 104.011 0.660
201803 0.719 105.290 0.900
201806 0.995 106.317 1.233
201809 1.237 106.507 1.530
201812 1.622 105.998 2.016
201903 1.897 107.251 2.331
201906 2.091 108.070 2.550
201909 2.342 108.329 2.849
201912 2.628 108.420 3.194
202003 2.696 108.902 3.262
202006 6.853 108.767 8.303
202009 6.522 109.815 7.826
202012 6.320 109.897 7.578
202103 6.579 111.754 7.758
202106 6.240 114.631 7.173
202109 6.273 115.734 7.142
202112 6.068 117.630 6.798
202203 6.831 121.301 7.421
202206 7.809 125.017 8.231
202209 9.366 125.227 9.856
202212 6.252 125.222 6.579
202303 6.093 127.348 6.305
202306 7.456 128.729 7.633
202309 9.563 129.860 9.704
202312 10.918 129.419 11.117
202403 12.553 131.776 12.553

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lantheus Holdings  (FRA:0L8) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Lantheus Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Lantheus Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lantheus Holdings (FRA:0L8) Business Description

Traded in Other Exchanges
Address
201 Burlington Road, South Building, Bedford, MA, USA, 01730
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Lantheus Holdings (FRA:0L8) Headlines

No Headlines